CAS 361442-04-8 Mimọ>99.0% (HPLC) API

Apejuwe kukuru:

Awọn itumọ ọrọ: BMS-477118;Onglyza

CAS: 361442-04-8

Mimọ:> 99.0% (HPLC)

Irisi: White Powder

API, Didara Giga, Ṣiṣejade Iṣowo

E-Mail: alvin@ruifuchem.com


Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Kemikali Properties:

Awọn itumọ ọrọ sisọ BMS-477118;Onglyza;(1S,3S,5S) -2- [(2S) -2-Amino-2- (3-Hydroxy-1-Adamantyl) acetyl] -2-Azabicyclo [3.1.0] hexane-3-Carbonitrile;(1S,3S,5S) -2- [(2S) -2-Amino-2- (3-Hydroxytricyclo [3.3.1.13,7] dec-1-yl) acetyl] -2-Azabicyclo [3.1.0] hexane -3-Carbonitrile
Nọmba CAS 361442-04-8
NỌMBA CAT RF-PI1991
Iṣura Ipo Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Fọọmu Molecular C18H25N3O2
Òṣuwọn Molikula 315.41
Brand Ruifu Kemikali

Awọn pato:

Nkan Awọn pato
Ifarahan Funfun Powder
Òórùn Iwa
idanimọ A: IR B: Aago Idaduro HPLC
Mimọ / Analysis Ọna > 99.0% (HPLC)
Wipe Omi Solusan Sihin, Alailowaya, Ko si Awọn ọrọ Idaduro
Sieve onínọmbà 100% Pass 80 Mesh
Ojuami Iyo 202.0 ~ 212.0 ℃
Pipadanu lori Gbigbe <0.50%
Sulfated Ash <0.20%
Yiyi pato + 174,0 ° ~ + 186,0 °
Aimọ Kanṣoṣo <0.50%
Lapapọ Awọn Aimọ <1.00%
Awọn irin Heavy <10ppm
Arsenic (Bi) <2.0ppm
Asiwaju (Pb) <1.0ppm
Cadmium (Cd) <1.0ppm
Awọn ohun elo ti o ku <100ppm
Ipakokoropaeku ti o ku Odi
Microbiology  
Apapọ Awo kika <1000cfu/g
Iwukara & Mold <100cfu/g
E. Kọli Odi
S. Aureus Odi
Salmonella Odi
Igbesi aye selifu Awọn oṣu 24 Lati Ọjọ iṣelọpọ ti o ba wa ni ipamọ daradara
Igbeyewo Standard Standard Enterprise
Lilo API;Iru 2 Àtọgbẹ mellitus

Package & Ibi ipamọ:

Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin

Awọn anfani:

1

FAQ:

Ohun elo:

(BMS-477118) (CAS: 361442-04-8) jẹ agbara, yiyan, iyipada, ifigagbaga ati ẹnu ti nṣiṣe lọwọ dipeptidyl peptidase-4 (DPP-4) (Ki = 0.6-1.3 nM) inhibitor.BMS-477118 ni peotential fun iwadii àtọgbẹ iru 2.BMS-477118jẹ oogun àtọgbẹ iru 2 ti o le mu ki oronro ṣiṣẹ lati ṣe agbejade insulin diẹ sii lẹhin ounjẹ.O ti de nipasẹ ifowosowopo ti AstraZeneca ati Bristol-Myers Squibb Company ati pe o jẹ ti inhibitor DPP-IV.BMS-477118ṣe ipa naa nipasẹ idilọwọ ibajẹ GLP-l.GLP-I jẹ awọn homonu ti a ṣẹda nipa ti ara ti o wa ninu ifun lẹhin ti o mu ounjẹ.O le ṣe ilana yomijade ti hisulini ati teramo lilo glukosi ninu awọn sẹẹli agbeegbe.Oogun ẹyọkan ti BMS-477118 le mu iṣakoso glukosi ẹjẹ pọ si ati oogun apapọ ti BMS-477118 pẹlu Metformin, Sulfonylurea ati Thiazolidinediones le mu ipa imularada pọ si.O yori si eewu kekere ti hypoglycemia ati awọn aati buburu rẹ jẹ iru si pilasibo, ti n ṣafihan ifarada ti o dara julọ.Ni Oṣu Keje Ọjọ 31, Ọdun 2009, BMS-477118 awọn tabulẹti (Onglyza), oogun tuntun ti iru àtọgbẹ 2, ṣe iwadii apapọ ati idagbasoke AstraZeneca ati Bristol-Myers Squibb ti fọwọsi nipasẹ US FDA.O le mu lẹẹkan lojoojumọ lati tọju iru àtọgbẹ 2 ni idapo pẹlu iṣakoso Ounjẹ ati adaṣe.

Kọ ifiranṣẹ rẹ nibi ki o si fi si wa